Boston Scientific Corp
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 1,767,855 | 1.6% | 18,540,693 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 1,369,997 | 1.2% | 14,032,541 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 1,784,674 | 1.8% | 16,615,529 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 1,790,041 | 2.1% | 17,744,264 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 1,992,994 | 2.1% | 22,312,967 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 1,823,363 | 1.9% | 21,758,579 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 1,716,153 | 1.9% | 22,284,802 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 1,412,547 | 1.6% | 20,624,129 | 3/31/2024 |
| 2023 Q4 | 2/16/2024 | 1,221,682 | 1.6% | 21,132,718 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 1,177,343 | 1.7% | 22,298,154 | 9/30/2023 |
| 2023 Q2 | 5/17/2024 | 1,162,505 | 1.8% | 21,492,124 | 6/30/2023 |
| 2023 Q1 | 5/17/2024 | 1,173,071 | 2.0% | 23,447,628 | 3/31/2023 |
| 2022 Q4 | 5/17/2024 | 1,082,436 | 1.9% | 23,393,853 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 841,792 | 1.6% | 21,734,422 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 775,455 | 1.4% | 20,806,144 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 740,433 | 1.1% | 16,717,555 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 424,684 | 0.6% | 9,880,415 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 546,550 | 0.9% | 12,595,226 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 658,328 | 1.1% | 15,395,194 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 554,358 | 1.0% | 14,341,890 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 270,763 | 0.6% | 7,614,617 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 231,180 | 0.6% | 6,050,230 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 121,947 | 0.3% | 3,473,278 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 242,813 | 0.8% | 7,441,408 | 3/31/2020 |
| 2019 Q4 | 3/12/2020 | 544,596 | 1.4% | 12,104,073 | 12/31/2019 |